| ARB | Angiotensin II receptor blocker |
| AUC | Area under the curve |
| CCB | Calcium channel blocker |
| CI | Confidence interval |
| CKD-EPI | Chronic Kidney Disease Epidemiology Collaboration |
| DOAC | Direct Oral Anticoagulant |
| eGFR | Estimated glomerular filtration rate |
| eNOS | Endothelial nitric oxide synthase |
| FMD | Flow-mediated dilation |
| HR | Hazard ratio |
| MRA | Mineralocorticoid receptor antagonist |
| NMD | Nitroglycerin-mediated dilation |
| NO | Nitric oxide |
| NSTEMI | Non-ST-elevation myocardial infarction |
| OR | Odds ratio |
| PCI | Percutaneous coronary intervention |
| PI | Pulsatility index |
| PSV | Peak systolic velocity |
| RAAS | Renin–angiotensin–aldosterone system |
| RAO | Radial artery occlusion |
| RI | Resistive index |
| RR | Relative risk |
| SD | Standard deviation |
| SGLT2i | Sodium-glucose cotransporter-2 inhibitor |
| STEMI | ST-elevation myocardial infarction |
| TRA | Transradial access |
| VTI | Velocity-time integral |